MedTrace Logo

Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy

NCT04221880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-16

No results posted yet for this study

Summary

Thoracotomy surgery is the most painful of all surgical procedures. Inadequate postoperative pain control in these patients may cause serious morbidity related to pulmonary, cardiovascular and emotional systems. Erector Spinae Plane Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in thoracic surgery. Intravenous lidocaine exhibit analgesic activity through both the peripheral and central nervous system. Intravenous lidocaine has been shown to reduce postoperative pain intensity and accelerate postoperative recovery in many surgeries.

The investigators aimed to compare the effect of lidocaine infusion and erector spinae plane block on postoperative opioid consumption and pain scores.

Conditions

  • Thoracic Diseases

Interventions

DRUG

Bupivacaine Hcl 0.25% Inj

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine

DRUG

Saline Solution for Block

Ultrasound-guided erector spinae plane block with 20 ml saline

DRUG

Saline Solution intravenously

Same volume saline solution bolus and infusion as Group Lidocaine

DRUG

Lidocaine

1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2022-03-01
Completion
2022-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04221880 on ClinicalTrials.gov